Newsroom

Sorted by: Latest

-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - June 08.05.2026 QJUN.LN IE000HFBJ0U0 3,700,002.00 USD 83,127,782.10 22.467  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Capital Strength ESG Leaders UCITS ETF 08.05.2026 FCSG IE00BKPSPT20 1,025,002.00 USD 44,005,369.66 42.932  ...
-

Therorna to Showcase Clinical-Ready Circular RNA in vivo CAR-T and CircRNA Pipeline at the 2026 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

BEIJING & SHANGHAI--(BUSINESS WIRE)--Therorna presents circRNA-based in vivo CAR-T, T-cell engager, and therapeutic cancer vaccine data at ASGCT 2026 in Boston....
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust RBA American Industrial Renaissance UCITS ETF 08.05.2026 AIRR LN IE000U6ABUJ7 6,100,002.00 USD 192,346,405.61 31.532  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF 10% - January 08.05.2026 FJAN.LN IE000MDKBOB3 150,002.00 USD 4,271,427.07 28.476  ...
-

HPE to Present Live Audio Webcast of Fiscal 2026 Second Quarter Earnings Conference Call

HOUSTON--(BUSINESS WIRE)--HPE (NYSE: HPE) will conduct a live audio webcast of a conference call with analysts to review financial results for the second quarter of fiscal 2026, ending April 30, 2026. The call is scheduled for Monday, June 1, at 4:00 p.m. CT (5:00 p.m. ET), and the webcast will be available at www.hpe.com/investor/2026Q2Webcast. A replay of the webcast will be available at the same website shortly after the call and will remain available for approximately one year. For addition...
-

Horizon Quantum Announces Participation in Upcoming Investor Conferences

SINGAPORE--(BUSINESS WIRE)--Horizon Quantum Holdings Ltd. (Nasdaq: HQ) (“Horizon Quantum,” "we," "us," or "our"), a pioneer of software infrastructure for quantum applications, today announced that Dr. Joe Fitzsimons, Founder & Chief Executive Officer, and Greg Gould, Chief Financial Officer, will participate in several upcoming investor conferences. 21st Annual Needham Technology, Media & Consumer Conference - On Tuesday, May 12th Dr. Fitzsimons will present and participate in a firesi...
-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

Rithm Capital Corp. Announces Proposed Offering of Senior Unsecured Notes

NEW YORK--(BUSINESS WIRE)--Rithm Capital Corp. (NYSE: RITM; “Rithm” or the “Company”) announced today that it plans to offer $500 million aggregate principal amount of senior unsecured notes due 2031 (the “notes”). The Company intends to use the net proceeds from this offering for general corporate purposes, which may include the repayment of certain indebtedness. The notes have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), any sta...
-

Aldevron and Minaris Renew Lentiviral Plasmid Agreement to Accelerate Gene-Modified Cell Therapy Development

FARGO, N.D. & PHILADELPHIA--(BUSINESS WIRE)--Aldevron, a Danaher company and global leader in the production of DNA, RNA and protein for genomic medicine, and Minaris, a global cell and gene therapy contract development and manufacturing organization (CDMO) and multimodality biosafety testing provider today announced a renewed licensing agreement that expands access to a proprietary, off-the-shelf lentiviral plasmid system for gene-modified cell therapy applications. This updated agreement help...